Foundation Medicine (NASDAQ:FMI)

CAPS Rating: 5 out of 5

Results 1 - 5 of 5

Recs

0
Member Avatar OklaBoston (68.16) Submitted: 3/29/2014 1:44:17 PM : Outperform Start Price: $29.37 FMI Score: -9.90

P/B on the high side but over 12% insider ownership and good Q/Q numbers make up for that.

Recs

0
Member Avatar GVFool15 (60.82) Submitted: 2/10/2014 10:06:07 PM : Outperform Start Price: $30.12 FMI Score: -15.34

If it's good enough for Google Ventures to be investing in, it's good enough for me. This pick is for fun!

Recs

0
Member Avatar usubanas (99.53) Submitted: 1/17/2014 3:11:08 PM : Outperform Start Price: $30.44 FMI Score: -14.32

The future is... here

Recs

0
Member Avatar NiksurfsInvestmt (35.78) Submitted: 12/25/2013 11:19:09 PM : Outperform Start Price: $25.98 FMI Score: -1.17

This could be the surprise of 2014. I believe it will get added to Medicare funding and Insurance Companies dockets, once that happens revenue and earnings will take off and so will this stock. Stay tuned………………….

Recs

0
Member Avatar awallejr (82.72) Submitted: 9/29/2013 12:33:06 PM : Outperform Start Price: $35.42 FMI Score: -36.36

Speculation on an IPO. Here's its profile:

"Foundation Medicine, Inc. provides various molecular information products in the United States. Its molecular information platform generates actionable genomic information about a patient?s individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. The company offers FoundationOne, a molecular information product for the analysis of routine cancer specimens in a clinical setting. It is also developing FoundationOne for hematologic malignancies."

Results 1 - 5 of 5

Featured Broker Partners


Advertisement